Chr. Hansen launches science-based probiotics for the pet segment
Introducing a new portfolio of stable live probiotics for use in pet foods and supplements, empowering every pet’s life stage with good bacteria
Pet food and supplements brands face many challenges. They need to continuously keep up with the pace of innovation and expectations of a new generation of millennial pet parents, who look for natural, safe, effective and sustainable solutions. Today
Chr. Hansen publishes first scientific study of Human Milk Oligosaccharides mix in natural concentrations in infant formula
New study published in “Nutrients” shows safety and tolerability of infant formula containing the five most abundant Human Milk Oligosaccharides in natural concentrations
Human Milk Oligosaccharides (HMOs) are the third most abundant components exclusively found in human breast milk. They are known to provide benefits to infants by supporting the immune system, promoting growth of beneficial gu
Chr. Hansen and Glycom settle patent disputes about Human Milk Oligosaccharides
Chr. Hansen A/S has reached a settlement with Glycom A/S of several patent disputes, including litigations in Denmark, relating to the production of Human Milk Oligosaccharides (HMOs)
The disputes were inherited by Chr. Hansen through the acquisition of Jennewein Biotechnologie GmbH in 2020.
As part of the settlement of the patent disputes, Chr. Hansen and Glycom have agreed on royalty-
Chr. Hansen’s Q3 in line with expectations: 4% organic growth
On track to deliver ambition for the year, outlook for 2020/21 unchanged
Q3 2020/21 organic sales growth was 4%, equally split between volume/mix and price. The Q3 organic growth was impacted by a reduced contribution from EUR-based pricing compared to the first half, and a higher comparable, as Q3 last year was positively impacted by COVID-19 related customer inventory build-up. YTD organic g
Bacthera receives manufacturing licenses in Switzerland and Denmark
Bacthera, Chr. Hansen’s joint venture with Lonza, reaches a key milestone and is ready to start supplying Live Biotherapeutic Products
Chr. Hansen launches global science-based online platform on probiotics
With more than 55 million hits on “probiotics” online, it can be hard to find science-based information from trustworthy sources. As an industry leader, Chr. Hansen is therefore launching The Probiotics Institute – a new platform providing educational and scientific content on probiotics and the human microbiome.
Chr. Hansen and Nestlé settle court case about Human Milk Oligosaccharides patent infringements
In October 2020, Chr. Hansen acquired Jennewein Biotechnologie GmbH including a strong patent portfolio relating to the production of Human Milk Oligosaccharides (HMOs) and several litigations related hereto.
Before the acquisition in January 2020, Jennewein requested an injunction at the courts of Mannheim, Germany, against Nestlé’s sale of its infant formula products containing HMOs from a t
Chr. Hansen launches VEGA™ Culture Kit specifically developed for fermented plant bases
The VEGA™ Culture Kit is comprised of customizable starter cultures, probiotics and bioprotective strains, specifically developed for fermented plant-bases.
Chr. Hansen launches the next generation of FreshQ® food cultures for fermentation- enabled bioprotection of dairy products
FreshQ® cultures, specifically developed to unlock the benefits of bioprotection for producers who may experience challenged cold chains, long fermentation, and in-process holding times.
New study: Probiotics may offer immune balancing benefits while improving sleep and stress of rotation shift workers
Irregular sleep patterns are associated with immune health and may underpin a range of health issues in rotation shift workers. By supporting the intestinal microbiota, probiotic supplements may lessen the negative impact of interrupted sleep on the immune system, new study suggests.
Chr. Hansen, in collaboration with Griffith University, recently completed a study* on the impact of stress, sle
Chr. Hansen continues strong momentum: 10% organic growth in Q2
Good results across business areas and regions secure upwards narrowing of full-year guidance. Extraordinary dividend announced for pay-out in May.
Continued strong organic growth momentum leads to upwards narrowing of full-year organic growth guidance.
Q2 2020/21 organic sales growth was 10%, equally split between volume/mix and price, and driven by Health & Nutrition which deliver